Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001839882-24-044356
Filing Date
2024-12-09
Accepted
2024-12-09 16:14:49
Documents
1
Group Members
AFFINITY HEALTHCARE FUND, LP

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G inozymepharma-sc13g_120224.htm SC 13G 42920
  Complete submission text file 0001839882-24-044356.txt   44598
Mailing Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210
Business Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210 857-330-4340
Inozyme Pharma, Inc. (Subject) CIK: 0001693011 (see all company filings)

EIN.: 475129768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91586 | Film No.: 241535265
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 767 THIRD AVENUE NEW YORK NY 10017
Business Address 767 THIRD AVENUE NEW YORK NY 10017 917-826-4533
Affinity Asset Advisors, LLC (Filed by) CIK: 0001773195 (see all company filings)

EIN.: 821567490 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G